(Q44446014)

3 December 2017

Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy (English)

1 reference

3 December 2017

1 reference

2

1 reference

3 December 2017

8

Gen Sobue

1 reference

3 December 2017

Masahisa Katsuno

1

1 reference

3 December 2017

Manabu Doyu

3

1 reference

3 December 2017

Makoto Minamiyama

4

1 reference

3 December 2017

Chen Sang

5

1 reference

3 December 2017

Yasushi Kobayashi

6

1 reference

3 December 2017

Akira Inukai

7

1 reference

3 December 2017

language of work or name

English

0 references

publication date

18 May 2003

1 reference

3 December 2017

1 reference

3 December 2017

9

1 reference

3 December 2017

6

1 reference

3 December 2017

768-773

1 reference

https://scigraph.springernature.com/pub.10.1038/nm878

3 December 2017

0 references

cites work

Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait

1 reference

Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy

21 January 2018

1 reference

Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene

21 January 2018

1 reference

Glutamine repeats and neurodegeneration

21 January 2018

1 reference

Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy

21 January 2018

1 reference

Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy

21 January 2018

1 reference

Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders

21 January 2018

1 reference

Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy

21 January 2018

1 reference

Mechanism of action and pure antiandrogenic properties of flutamide

21 January 2018

1 reference

Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

21 January 2018

1 reference

The subnuclear three-dimensional image analysis of androgen receptor fused to green fluorescence protein

21 January 2018

1 reference

Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy

21 January 2018

1 reference

Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila.

21 January 2018

1 reference

Androgen receptor mutation in Kennedy's disease

21 January 2018

1 reference

Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor

21 January 2018

1 reference

21 January 2018

Androgen insensitivity.

1 reference

Defects of androgen receptor function: from sex reversal to motor neurone disease

21 January 2018

1 reference

Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.

21 January 2018

1 reference

Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice

21 January 2018

1 reference

Histone deacetylase inhibitors reduce polyglutamine toxicity

21 January 2018

1 reference

Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila

21 January 2018

1 reference

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

21 January 2018

1 reference

Efficient selection for high-expression transfectants with a novel eukaryotic vector

21 January 2018

1 reference

Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death

21 January 2018

1 reference

Daily dosing with flutamide or Casodex exerts maximal antiandrogenic activity

21 January 2018

1 reference

Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias

21 January 2018

1 reference

Altered acetylation in polyglutamine disease: an opportunity for therapeutic intervention?

21 January 2018

1 reference

X-linked recessive bulbospinal neuronopathy. A clinicopathological study

21 January 2018

1 reference

7 January 2021

Subclinical phenotypic expressions in heterozygous females of X-linked recessive bulbospinal neuronopathy

1 reference

7 January 2021

Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families

1 reference

7 January 2021

Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women

1 reference

7 January 2021

Founder effect in spinal and bulbar muscular atrophy (SBMA)

1 reference

7 January 2021

Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy

1 reference

7 January 2021

Agonist and antagonist activities of hydroxyflutamide and casodex relate to androgen receptor stabilization

1 reference

7 January 2021

Neural androgen receptor regulation: effects of androgen and antiandrogen

1 reference

7 January 2021

Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract

1 reference

7 January 2021

Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein

1 reference

7 January 2021

Caspase-3 cleaves the expanded androgen receptor protein of spinal and bulbar muscular atrophy in a polyglutamine repeat length-dependent manner

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM878

1 reference

Dimensions Publication ID

3 December 2017

0 references

1 reference